Exploratory Cellular Therapies

Exploratory Cellular
Therapies

Investigational autologous pathways under medical supervision.

Responsibly Explored Regenerative Science

Understanding
how the human
body heals

At MBR Health, we investigate how a person’s own biologic activity interacts with tissues across the respiratory, neurological, liver, kidney, and musculoskeletal systems. These exploratory pathways are supported by advanced imaging, biological monitoring, and medically supervised autologous approaches.

All pathways are exploratory only and provided under the Therapeutic Goods (Autologous Human Cells and Tissues) Determination 2018.

Our regenerative research focus.

At MBR Health, our exploratory cellular therapies work uses a person’s own blood or tissues, known as autologous material. These materials are prepared using minimal manipulation and delivered with image guidance for accurate placement.

MBR Health is involved in exploratory work using platelet-rich plasma (PRP) and bone marrow concentrate (which contains mesenchymal stem cells) across a range of biological contexts throughout the body.

All pathways are investigational and exploratory in nature, with no therapeutic claims made or implied. As part of this process, we also assess healing and biological change through serial MRI imaging to better understand the underlying biological patterns and the rate at which tissues may respond over time.

Insights

The latest from MBR Health.

Read More Insights

Cellular Therapies We Explore

Lungs

Investigating how autologous biologics may interact with chronic sinusitis, rhinitis, COPD, and interstitial lung disease.

Brain & Spine

Exploratory research into CSF leaks, neurodegenerative conditions, spinal trauma, and neuro-biological response patterns.

Liver & Kidney

Investigating biological interactions in fatty liver disease and acute or chronic kidney concerns.

Musculoskeletal

Beyond high-dose PRP for tendons, ligaments, and joints, we explore pathways for delayed bone healing and non-union states.

Important Information

Exploratory Pathways Only.

The pathways offered at MBR Health are exploratory and experimental in nature. They are not medical treatments and are not provided to diagnose, prevent, treat, or cure any medical condition. No therapeutic claims, promises of improvement, or guarantees of benefit are made or implied.

All pathways use a person’s own minimally manipulated blood or tissues (autologous biologics) and are offered only under medical supervision with full informed consent. Outcomes can vary widely between individuals and may be influenced by factors such as underlying health conditions, lifestyle, medications, and biological variability.

Information provided by MBR Health is general in nature and should not be interpreted as personal medical advice. Individuals should discuss their health concerns with a qualified healthcare professional before making decisions about their care.

What are Cellular Therapies?

A regenerative method focused on repair.

Cellular therapies aim to restore, repair, or replace human cells, tissues, or biological functions using the body’s own healing mechanisms. Many tissues—including brain, spinal cord, cartilage, nerves, and tendons—do not regenerate easily.

Regenerative medicine seeks to understand
and support these biological processes through:

  1. Studying how repair works.
  2. Exploring inflammation and recovery.
  3. Understanding cell signalling.
  4. Monitoring tissue-level change.

Research Output

Regenerative Medicine Publications

01.

Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367(9522):1618–1625.

02.

Schug SA, et al. Persistent pain after surgery: Pathophysiology and treatment. Br J Anaesth. 2017;119(3):532–540.

Take the Next Step

Speak with our
research team.

Our team combines world-leading imaging with evidence-based care to ensure every next step is informed, precise, and designed around you.
Enquire about exploratory pathways